MAPT and Alzheimer disease: Peripheral insulin resistance can promote AD onset by increasing the levels of Aβ, Tau phosphorylation, oxidative stress, proinflammatory cytokines, advanced glycation end products, and apoptosis in the brain (Craft, 2005; Sims-Robinson et al., 2010; Cholerton et al., 2011).